Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (341-350 of 455) with videos related to

Pageof 46
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 29, 2025
The separate and combined effects of GIP, GLP-1 and GLP-2 on markers of bone turnover in type 2 diabetesJosefine V Hansen, David S Mathiesen, Mikkel B Christensen, et al.
Diabetes, Obesity & Metabolism|June 17, 2020
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trialNicklas J Johansen, Thomas F Dejgaard, Asger Lund, et al.
Basic & Clinical Pharmacology & Toxicology|April 5, 2017
Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of GlucoseRikke M Røge, Jonatan I Bagger, Oskar Alskär, et al.
The Journal of Clinical Endocrinology and Metabolism|December 11, 2025
Distribution of Somatostatin and its Receptors in the Intestinal Tract in Healthy and in Patients with Type 2 DiabetesSophie W Nielsen, Hannah Gilliam-Vigh, Tina Jorsal, et al.
Diabetes Care|July 3, 2025
Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 DiabetesHenrik Maagensen, Johanne S Jensen, Stine O Høyerup, et al.
Diabetes Care|October 11, 2023
Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled TrialCasper K Nielsen, Caroline C Øhrstrøm, Inas J K Houji, et al.
The Lancet. Gastroenterology & Hepatology|July 22, 2022
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trialMartin L Kårhus, Andreas Brønden, Julie L Forman, et al.
European Journal of Endocrinology|January 18, 2023
The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humansLiva S L Krogh, Kristine Henriksen, Signe Stensen, et al.
Diabetes|March 30, 2026
LEAP2 Reduces Ad Libitum Food Intake and Attenuates Postprandial Glucose Excursions in Men With ObesityAnders Englund, Andreas H Lange, Christoffer A Hagemann, et al.
Bone|July 31, 2020
The role of endogenous GIP and GLP-1 in postprandial bone homeostasisMads M Helsted, Lærke S Gasbjerg, Amalie R Lanng, et al.
Pageof 46

Showing results (341-350 of 455) with videos related to

Sort By:
Pageof 46
The Journal of Clinical Endocrinology and Metabolism|August 29, 2025
The separate and combined effects of GIP, GLP-1 and GLP-2 on markers of bone turnover in type 2 diabetesJosefine V Hansen, David S Mathiesen, Mikkel B Christensen, et al.
Diabetes, Obesity & Metabolism|June 17, 2020
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trialNicklas J Johansen, Thomas F Dejgaard, Asger Lund, et al.
Basic & Clinical Pharmacology & Toxicology|April 5, 2017
Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of GlucoseRikke M Røge, Jonatan I Bagger, Oskar Alskär, et al.
The Journal of Clinical Endocrinology and Metabolism|December 11, 2025
Distribution of Somatostatin and its Receptors in the Intestinal Tract in Healthy and in Patients with Type 2 DiabetesSophie W Nielsen, Hannah Gilliam-Vigh, Tina Jorsal, et al.
Diabetes Care|July 3, 2025
Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 DiabetesHenrik Maagensen, Johanne S Jensen, Stine O Høyerup, et al.
Diabetes Care|October 11, 2023
Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled TrialCasper K Nielsen, Caroline C Øhrstrøm, Inas J K Houji, et al.
The Lancet. Gastroenterology & Hepatology|July 22, 2022
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trialMartin L Kårhus, Andreas Brønden, Julie L Forman, et al.
European Journal of Endocrinology|January 18, 2023
The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humansLiva S L Krogh, Kristine Henriksen, Signe Stensen, et al.
Diabetes|March 30, 2026
LEAP2 Reduces Ad Libitum Food Intake and Attenuates Postprandial Glucose Excursions in Men With ObesityAnders Englund, Andreas H Lange, Christoffer A Hagemann, et al.
Bone|July 31, 2020
The role of endogenous GIP and GLP-1 in postprandial bone homeostasisMads M Helsted, Lærke S Gasbjerg, Amalie R Lanng, et al.
Pageof 46